Just how well does Gilead Sciences’ Covid-19 drug work? Is politics getting in the way of public health? And who gets the eventual coronavirus vaccine first?
We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we break down the latest positive data on remdesivir, Gilead’s closely watched treatment for Covid-19. Then, we’re joined by former FDA Commissioner Scott Gottlieb for a wide-ranging discussion about reopening the U.S., vaccines for coronavirus, and the politicization of public health.
For more on what we cover, here’s the news on remdesivir, and here’s the latest on the coronavirus outbreak.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
